The FTX Trial: Unveiling Financial Deceit and Disappearing Billions

Former FTX CEO Sam Bankman-Fried's defense team has raised concerns about his lack of access to his prescribed dosage of Adderall, a medication he takes for ADHD, during his trial on federal fraud charges. They argue that his ability to concentrate and meaningfully participate in his defense may be compromised. To address this, his defense team has secured an extended-release form of Adderall to help him maintain focus throughout the day in court. The defense's concerns could potentially set the stage for an appeal on the grounds that Bankman-Fried was unable to participate meaningfully in his defense due to the lack of medication. However, some legal experts question the validity of a medication-related appeal, given Bankman-Fried's educational background and the high-profile nature of the trial. The trial is set to resume next Thursday.